Paul Gougis

16PUBLICATIONS
90CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 29, 2026
Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.

|Jan 07, 2026
CXCR6+ T Cells Drive Immune Checkpoint Inhibitor Myocarditis.

Amir Z Munir, Alan Gutierrez, Cade J Krawiec

|Nov 19, 2025
Response to Letters Regarding "Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors".

Léonard Laurent, Baptiste Abbar, Paul Gougis

|Nov 14, 2025
Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective study.

Coraline Cheuvart, Paul Gougis, Luca Campedel

|Sep 26, 2025
Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial.

Floriane Jochum, Élise Dumas, Joe-Elie Salem

|Aug 24, 2025
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2- Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial.

Enora Laas, Anne-Sophie Hamy, Thomas Bachelot

Pageof 3

Frequent Collaborators

5 joint publications

Anne-Sophie Hamy

5 joint publications

Floriane Jochum

4 joint publications

Baptiste Abbar

4 joint publications

Enora Laas